drugset / Trial / NCT01931241
Safety Study of Bile Acid to Treat Hypercholesteremia
RandomizedSingle-groupQuadruple-blindTreatment
Summary
Preclinical data support the hypothesis that the administration of AHRO-001 reduces LDL cholesterol levels, improves HDL function, and finally, decreases atheromatous plaque burden.
Timeline
- Start
- 2013-06
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HYODEOXYCHOLIC_ACID | Small molecule | 500 mg | Oral |
| Subject | HYODEOXYCHOLIC_ACID | Small molecule | 750 mg | Oral |
| Subject | HYODEOXYCHOLIC_ACID | Small molecule | 1000 mg | Oral |